Pharmacology
Conference Coverage
Gut microbiome may predict nivolumab efficacy in gastric cancer
The diversity of the gut microbiome could potentially predict nivolumab response.
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
Could an osteoporosis drug reduce need for hip revision surgery?
Denosumab, widely used to treat osteoporosis, may reduce the need for revision surgery due to aseptic loosening of the prosthesis in patients with...
News
Treprostinil offers some benefits for patients with ILD-associated pulmonary hypertension
The INCREASE trial was multicenter, randomized, double blind, and placebo controlled.
News
Averting COVID hospitalizations with monoclonal antibodies
News
DOACs look safe in elective endoscopic procedures
The study also found delaying resumption of anticoagulants provided no benefit.
News
Far too few with treatment-resistant hypertension get hormone test
“Testing rates also did not change meaningfully over nearly 2 decades ... despite an increasing number of guidelines recommending testing for...
News
FDA okays first generic injected glucagon for hypoglycemia
The new generic will have the advantage of lower cost.
News
Temper enthusiasm for long-term treatment with bisphosphonates?
A real-world study of nearly 30,000 women shows no benefit, in terms of hip fracture risk, between taking oral bisphosphonates for 10 years vs. 5...